Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Analysis of complaint rates identified a world-wide occurrence of 0.12% of patients experiencing tibial plateau fractures. analysis of the reported complaints has shown that should a tibia fracture occur it is identified by the treating orthopedic consultant within an average of 25 days from primary surgery and available data indicate that 17% of those fractures have been treated conservatively. the oxford cementless tibial trays have been manufactured according to pre-defined specifications. an investigation into the cause of the reported tibial plateau fractures has revealed the importance that certain steps described in the applicable surgical technique are followed to reduce the risk of tibia plateau fractures. by means of this notice we would like to emphasize the importance of adhering to the applicable surgical technique and the appropriate sections in the instruction for use packaged with the products.
“The safety of patients has always been, and continues to be, Zimmer Biomet’s top priority and it is our honor to be a leader in this industry for the past 90 years,” Zimmer Biomet told ICIJ in a statement. “We adhere to strict regulatory standards, and work closely with the FDA and all applicable regulatory agencies in each of our regions as part of our commitment to operating a first-rate quality management system across our global manufacturing network. The company added that it is focused on staying at the forefront of innovation and doing right by the millions of patients who rely on the company’s products.